Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells

Hidemasa Tamai, Satoshi Watanabe, Rongxiu Zheng, Katsuya Deguchi, Peter A. Cohen, Gary K. Koski, Suyu Shu

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

Curative immunotherapy against spontaneous metastases of poorly immunogenic tumors has been difficult to demonstrate, but it is highly relevant to clinical disease conditions. The 4T1 mammary carcinoma shares many characteristics of human mammary cancer. Here, mice with 4T1 spontaneous metastases were treated effectively with a combination of dendritic (DC)-tumor hybrid vaccination and adoptive transfer of tumor-draining lymph node-derived immune T cells. This strategy significantly prolonged survival and cured some mice. In this model, the combined immunotherapy induced a dramatic increase of T cells in the lung where metastases were located and in the spleen where tumor was not present. The mechanism of increasing numbers of T cells is likely attributed to the ability of DC-tumor hybrids to stimulate vigorous proliferation of adoptively transferred T cells rather than to promote their infiltration into tumor-harboring and lymphoid organs. Taken together, the combined approach may be useful for clinical development of cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)66-77
Number of pages12
JournalClinical Immunology
Volume127
Issue number1
DOIs
StatePublished - Apr 1 2008

Keywords

  • Adoptive immunotherapy
  • Cancer vaccine
  • Dendritic-tumor fusion hybrids
  • Immunotherapy
  • Murine 4T1 mammary carcinoma
  • Spontaneous metastases
  • Tumor-draining lymph node (TDLN) T cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells'. Together they form a unique fingerprint.

  • Cite this